{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-010412","form_type":"8-K/A","ticker":"OCEA","cik":"0001869974","company_name":"Ocean Biomedical, Inc.","filed_at":"2023-03-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.285649+00:00","generated_at":"2026-06-17T08:28:45.627284+00:00","sec_items":["9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Ocean Biomedical files audited FY2022 financials; auditor flags going concern with $34K cash vs $12.7M liabilities","bullets":["Cash at Dec 31, 2022: $34K; total current liabilities $12.7M; working capital deficit of $10.8M.","Auditor's report includes going-concern emphasis: substantial doubt about ability to continue.","Net loss for FY2022 not disclosed in this excerpt, but accumulated deficit and negative equity implied.","Deferred offering costs of $1.8M suggest ongoing capital-raising efforts.","Short-term loans of $776K outstanding; accounts payable and accrued expenses $11.4M."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-010412","json":"https://secwatch.observer/filing/0001493152-23-010412.json","markdown":"https://secwatch.observer/filing/0001493152-23-010412.md","text":"https://secwatch.observer/filing/0001493152-23-010412.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1869974/000149315223010412/0001493152-23-010412-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1869974/000149315223010412/form8-ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T08:28:45.627284+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}